3Lok AS, McMahon BJ; Practice Cuidelines Committee, et al.Chronic hepatitis B: update of recommendations [J]. Hepatology, 2004,39(3):857 被引量：1
4Perrillo R, Hann HW, Mutimer D, et al. Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus [J]. Gastroenterology, 2004,126(1):81. 被引量：1
5Hanazaki K, Kajikawa S, Shimozawa N, et al. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma [J]. J Am Coll Surg, 2000,191(4):381 被引量：1
6Roayaie S, Frischer JS, Emre SH, et al. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters[J]. Ann Surg, 2002,235 (4): 533 被引量：1
7Yoo HY, Patt CH, Geschwind JF, et al. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time [J]. J Clin Oncol, 2003,21(23):4329 被引量：1
8Schwartz JD, Schwartz M, Mandeli J, et al. Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials [J]. Lancet Oncol, 2002,3(10):593. 被引量：1
